Related references
Note: Only part of the references are listed.Kinome-wide Selectivity Profiling of ATP-competitive Mammalian Target of Rapamycin (mTOR) Inhibitors and Characterization of Their Binding Kinetics
Qingsong Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Characterization of GSK2334470, a novel and highly specific inhibitor of PDK1
Ayaz Najafov et al.
BIOCHEMICAL JOURNAL (2011)
Discovery of a potent and highly selective PDK1 inhibitor via fragment-based drug discovery
Daniel A. Erlanson et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
PDK1 Attenuation Fails to Prevent Tumor Formation in PTEN-Deficient Transgenic Mouse Models
Katharine Ellwood-Yen et al.
CANCER RESEARCH (2011)
Targeting PI3K/mTOR Signaling in Cancer
Brooke M. Emerling et al.
CANCER RESEARCH (2011)
Functions and regulation of the 70 kDa ribosomal S6 kinases
Tim R. Fenton et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2011)
Structure-Based Design of Potent and Selective 3-Phosphoinositide-Dependent Kinase-1 (PDK1) Inhibitors
Jesus R. Medina et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Characterization of PF-4708671, a novel and highly specific inhibitor of p70 ribosomal S6 kinase (S6K1)
Laura R. Pearce et al.
BIOCHEMICAL JOURNAL (2010)
AZD8055 Is a Potent, Selective, and Orally Bioavailable ATP-Competitive Mammalian Target of Rapamycin Kinase Inhibitor with In vitro and In vivo Antitumor Activity
Christine M. Chresta et al.
CANCER RESEARCH (2010)
Discovery of PDK1 Kinase Inhibitors with a Novel Mechanism of Action by Ultrahigh Throughput Screening
Ekaterina V. Bobkova et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
The nuts and bolts of AGC protein kinases
Laura R. Pearce et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2010)
COSMIC (the Catalogue of Somatic Mutations in Cancer): a resource to investigate acquired mutations in human cancer
Simon A. Forbes et al.
NUCLEIC ACIDS RESEARCH (2010)
Regulation of 3-Phosphoinositide-Dependent Protein Kinase 1 Activity by Homodimerization in Live Cells
Thomas A. Masters et al.
SCIENCE SIGNALING (2010)
Ku-0063794 is a specific inhibitor of the mammalian target of rapamycin (mTOR)
Juan M. Garcia-Martinez et al.
BIOCHEMICAL JOURNAL (2009)
AKT-Independent Signaling Downstream of Oncogenic PIK3CA Mutations in Human Cancer
Krishna M. Vasudevan et al.
CANCER CELL (2009)
mTOR complex 2 (mTORC2) controls hydrophobic motif phosphorylation and activation of serum- and glucocorticoid-induced protein kinase 1 (SGK1)
Juan M. Garcia-Martinez et al.
BIOCHEMICAL JOURNAL (2008)
Small-Molecule Inhibitors of PDK1
Christian Peifer et al.
CHEMMEDCHEM (2008)
Mutation of the PDK1 PH domain inhibits protein kinase B/Akt, leading to small size and insulin resistance
Jose R. Bayascas et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
Intramolecular and intermolecular interactions of protein kinase B define its activation in vivo
Veronique Calleja et al.
PLOS BIOLOGY (2007)
Ablation in mice of the mTORC components raptor, rictor, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKCα but not S6K1
David A. Guertin et al.
DEVELOPMENTAL CELL (2006)
SIN1/MIP1 maintains rictor-mTOR complex integrity and regulates Akt phosphorylation and substrate specificity
Estela Jacinto et al.
CELL (2006)
Multiallelic disruption of the rictor gene in mice reveals that mTOR complex 2 is essential for fetal growth and viability
Chiyo Shiota et al.
DEVELOPMENTAL CELL (2006)
Evaluation of approaches to generation of tissue-specific knock-in mice
Jose R. Bayascas et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Perturbations of the AKT signaling pathway in human cancer
DA Altomare et al.
ONCOGENE (2005)
In vivo role of the phosphate groove of PDK1 defined by knockin mutation
BJ Collins et al.
JOURNAL OF CELL SCIENCE (2005)
Hypomorphic mutation of PDK1 suppresses tumorigenesis in PTEN+/- mice
JR Bayascas et al.
CURRENT BIOLOGY (2005)
Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex
DD Sarbassov et al.
SCIENCE (2005)
PDK1, the master regulator of AGC kinase signal transduction
A Mora et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2004)
Inappropriate activation of the TSC/Rheb/mTOR/S6K cassette induces IRS1/2 depletion, insulin resistance, and cell survival deficiencies
OJ Shah et al.
CURRENT BIOLOGY (2004)
Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton
DD Sarbassov et al.
CURRENT BIOLOGY (2004)
The TSC1-2 tumor suppressor controls insulin-PI3K signaling via regulation of IRS proteins
LS Harrington et al.
JOURNAL OF CELL BIOLOGY (2004)
Structural insights into the regulation of PDK1 by phosphoinositides and inositol phosphates
D Komander et al.
EMBO JOURNAL (2004)
In vivo role of the PIF-binding docking site of PDK1 defined by knock-in mutation
BJ Collins et al.
EMBO JOURNAL (2003)
Binding of phosphatidylinositol 3,4,5-trisphosphate to the pleckstrin homology domain of protein kinase B induces a conformational change
CC Milburn et al.
BIOCHEMICAL JOURNAL (2003)
MTOR interacts with Raptor to form a nutrient-sensitive complex that signals to the cell growth machinery
DH Kim et al.
CELL (2002)
High-resolution structure of the pleckstrin homology domain of protein kinase B/Akt bound to phosphatidylinositol (3,4,5)-trisphosphate
CC Thomas et al.
CURRENT BIOLOGY (2002)
High-level and high-throughput recombinant protein production by transient transfection of suspension-growing human 293-EBNA1 cells
Y Durocher et al.
NUCLEIC ACIDS RESEARCH (2002)
The PIF-binding pocket in PDK1 is essential for activation of S6K and SGK, but not PKB
RM Biondi et al.
EMBO JOURNAL (2001)
Share Paper
